ArticleCancer science2025

A Phase I, First-In-Human Study of CBA-1205, an Anti-DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors.

Yuki Katsuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.